Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.
Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.
The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.
The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.
The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.
In the past year, there has been a record number of new medical AI submissions, resulting in 300 new clinical AI clearances. The number of submissions has been steadily rising over the past decade.
After issuing a 50% tariff on copper imports this week, President Donald Trump said a massive levy on drugs could be announced “very soon.” The details are currently unknown.
Shareholders of the retail pharmacy giant voted in favor of the terms of the sale to Sycamore Partners for $11.45 a share. The deal is expected to close later this year.
Experts are hopeful the software can bring more objectivity to the diagnostic process by giving providers visual evidence of alterations in brain activity.
Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
